EV
Evelo Biosciences, Inc.
EVLO · OTC
$0.00 +0.00% (+$0.00)
1M -99.00%
Market Cap $1.90K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 201.37%
ROA 177.72%
Asset turnover 0.00x
Debt
71 /100
Low Current ratio 4.16x
Int. coverage -23.31x
Net debt/EBITDA -0.03x
Stability
54 /100
Moderate Beta 1.31x
EPS volatility 21.29%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na EVLO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Craig R. Jalbert
Employees
66
Headquarters
Cambridge
Nadcházející události
17 LIS
Earnings
Upcoming earnings report